Clinical trial
Procalcitonin Level and the High Risk of Mortality in 30 Days , in Critically Ill Patients Infected by SARS-CoV-2, Experience of a North African Hospital University , Cases Series.
NCT05008016 is registered in ClinicalTrials.gov with Mohammed VI University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Procalcitonin Level and the High Risk of Mortality in 30 Days , in Critically Ill Patients Infected by SARS-CoV-2, Experience of a North African Hospital University , Cases Series.
- Lead sponsor
- Mohammed VI University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- January 31, 2021
- Enrollment
- 582 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
the relationship between procalcitonin and 30-day mortality in covid patients